Menu
Products

Products

RedHill Biopharma is dedicated to the development and commercialization of proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases, including cancer

 

Products - RedHill has a U.S. co-promotion agreement with a subsidiary of Concordia International Corp. (NASDAQ: CXRX) (TSX: CXR) for Donnatal®, a prescription oral adjunctive drug used in the treatment of IBS and acute enterocolitis.
 
Pipeline - RedHill's pipeline of  late-stage, proprietary development programs includes three Phase III programs for gastrointestinal disease, as well as several Phase II programs in oncology and gastrointestinal diseases.